The Veteran is seeking service connection for Type 2 Diabetes Mellitus, which he claims is related to his military service and exposure to Agent Orange. The case has been remanded due to the need for a new VA examination by an endocrinologist experienced in diagnosing and treating DM.
The deciding factor: The claim requires further development as there is uncertainty regarding whether the Veteran has a valid diagnosis of Type 2 Diabetes Mellitus, necessitating a new VA examination.
- Claimed conditions
- Type 2 Diabetes Mellitus
- How they argued it
- Direct service connection
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- February 7, 2011
- Citation
- 1104950
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1104950.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for a right hip disability and type 2 diabetes mellitus, finding that the evidence did not support an in-service disease or injury related to these conditions.,Both the right hip disability and type 2 diabetes mellitus were found to have no onset during service or within one year of separation from service.
- Denied
The Board denied the claims for increased ratings for diabetes mellitus, hypertension, and hypothyroidism, as well as remanded the claims for service connection of left and right hip disabilities.
- Remanded (sent back)
The Board has remanded the claims for service connection for type 2 diabetes mellitus and peripheral neuropathy of the bilateral lower extremity due to potential association with in-service symptoms.
- Denied
The Board has denied the appeal challenging the reduction of the Veteran's type 2 diabetes mellitus rating from 60 percent to 20 percent, effective May 1, 2023. The evidence shows improvement in ability to function under ordinary conditions of life and work.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.